tiprankstipranks
Immunovia AB (IMMVF)
:IMMVF
US Market

Immunovia AB (IMMVF) Income Statement

Compare
36 Followers

Immunovia AB Income Statement

Last quarter (Q3 2022), Immunovia AB's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Immunovia AB's net income was $-22.93M. See Immunovia AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 15.81M$ 40.38M$ 27.07M$ 25.39M$ 24.19M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 19.06M$ 9.76M$ 8.45M$ 2.78M$ 1.26M
EBITDA
$ -135.47M$ -134.85M$ -104.75M$ -83.75M$ -43.96M
Operating Income
$ -166.74M$ -134.68M$ -114.35M$ -88.23M$ -45.58M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -155.97M$ -146.03M$ -114.52M$ -86.54M$ -45.23M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Immunovia AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis